Skip to content
healthcare.dev

Terazosin

NDC 42291-820, Terazosin Hydrochloride, capsule, from AvKARE.

Product NDC
42291-820
Status
Listed
Labeler
AvKARE
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE1 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
42291-820-10422910820101000 CAPSULE in 1 BOTTLE (42291-820-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a2137488-8554-e84f-e053-2995a90a796c

Use it

Look up 42291-820 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-820 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.